Protalix Biotherapeutics Inc. (PLX)
Market Closed
15 Jun, 20:00
$
2. 06
-0.03
-1.4354%
$
165.17M Market Cap
12.78 P/E Ratio
- Div Yield
561,635 Volume
0.21 Eps
$ 2.09
Previous Close Want to track PLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Protalix Biotherapeutics Inc. (PLX) Statistics
Valuation metrics
Market Cap 165.17M
Enterprise value 135.16M
Trailing P/E (ttm) 10.88
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 2.2
Price/Book (mrq) 2.48
Enterprise Value/Revenue 1.77
Enterprise Value/EBITDA 6.34
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 447.07K
Average volume (90 days) 826.72K
Price summary
52-Week low 1.32
52-Week high 3.19
Beta -
50-Day moving average 2.03
200-Day moving average 2.21
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 20 Dec 2019
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.2%
Operating margin 0.26%
Operational effectiveness
Return on assets 0.15%
Return on equity 0.28%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.96
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.19
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.65
Total debt (mrq) -
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 3.15%
Book value per share (mrq) 0.84
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
